Brokerages expect Genasys Inc. (NASDAQ:GNSS) to report sales of $9.60 million for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for Genasys’ earnings. The lowest sales estimate is $9.20 million and the highest is $10.00 million. Genasys posted sales of $8.28 million during the same quarter last year, which would indicate a positive year over year growth rate of 15.9%. The business is scheduled to issue its next earnings report on Monday, May 10th.
According to Zacks, analysts expect that Genasys will report full-year sales of $46.40 million for the current financial year, with estimates ranging from $46.30 million to $46.50 million. For the next year, analysts anticipate that the firm will report sales of $55.30 million. Zacks’ sales calculations are an average based on a survey of research analysts that that provide coverage for Genasys.
Genasys (NASDAQ:GNSS) last issued its earnings results on Monday, February 8th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.01 by ($0.03). Genasys had a return on equity of 13.45% and a net margin of 27.61%.
In related news, major shareholder Awm Investment Company, Inc. sold 101,000 shares of the company’s stock in a transaction on Monday, November 30th. The shares were sold at an average price of $7.07, for a total transaction of $714,070.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Daniel H. Mccollum sold 20,000 shares of the company’s stock in a transaction on Monday, December 14th. The stock was sold at an average price of $6.46, for a total transaction of $129,200.00. Following the transaction, the director now owns 32,500 shares of the company’s stock, valued at approximately $209,950. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 208,616 shares of company stock valued at $1,447,622. 4.80% of the stock is owned by company insiders.
Institutional investors have recently added to or reduced their stakes in the stock. Charles Schwab Investment Management Inc. raised its stake in Genasys by 18.8% during the third quarter. Charles Schwab Investment Management Inc. now owns 103,803 shares of the company’s stock valued at $639,000 after purchasing an additional 16,422 shares in the last quarter. O Shaughnessy Asset Management LLC raised its stake in Genasys by 7.7% during the third quarter. O Shaughnessy Asset Management LLC now owns 49,614 shares of the company’s stock valued at $305,000 after purchasing an additional 3,555 shares in the last quarter. Ritholtz Wealth Management purchased a new stake in Genasys during the third quarter valued at $78,000. California Public Employees Retirement System raised its stake in Genasys by 3.9% during the third quarter. California Public Employees Retirement System now owns 69,100 shares of the company’s stock valued at $425,000 after purchasing an additional 2,600 shares in the last quarter. Finally, GSA Capital Partners LLP purchased a new stake in Genasys during the third quarter valued at $168,000. 55.79% of the stock is currently owned by institutional investors.
GNSS stock traded down $0.26 on Friday, hitting $6.94. The company had a trading volume of 3,064 shares, compared to its average volume of 205,206. Genasys has a 12-month low of $2.01 and a 12-month high of $8.32. The stock’s 50-day simple moving average is $7.36 and its 200 day simple moving average is $6.27. The stock has a market cap of $233.47 million, a price-to-earnings ratio of 21.18 and a beta of 0.68.
Genasys Company Profile
Genasys is a global provider of critical communications solutions to help keep people safe. During public safety threats and critical business events, the Company?s unified platform of LRAD(TM) systems, Critical Communications as a Service software and integrated solutions provides a multi-channel approach to deliver geo-targeted alerts, notifications, instructions and information before, during and after crisis situations.
Featured Story: Trading on Margin
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Genasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genasys and related companies with MarketBeat.com's FREE daily email newsletter.